These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24628412)

  • 1. The intestinal microbiome in type 1 diabetes.
    Dunne JL; Triplett EW; Gevers D; Xavier R; Insel R; Danska J; Atkinson MA
    Clin Exp Immunol; 2014 Jul; 177(1):30-7. PubMed ID: 24628412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.
    Gianchecchi E; Fierabracci A
    Immunol Res; 2017 Feb; 65(1):242-256. PubMed ID: 27421719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetes: role of intestinal microbiome in humans and mice.
    Boerner BP; Sarvetnick NE
    Ann N Y Acad Sci; 2011 Dec; 1243():103-18. PubMed ID: 22211896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):265-70. PubMed ID: 23743644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity.
    Zhang XS; Li J; Krautkramer KA; Badri M; Battaglia T; Borbet TC; Koh H; Ng S; Sibley RA; Li Y; Pathmasiri W; Jindal S; Shields-Cutler RR; Hillmann B; Al-Ghalith GA; Ruiz VE; Livanos A; van 't Wout AB; Nagalingam N; Rogers AB; Sumner SJ; Knights D; Denu JM; Li H; Ruggles KV; Bonneau R; Williamson RA; Rauch M; Blaser MJ
    Elife; 2018 Jul; 7():. PubMed ID: 30039798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    Needell JC; Dinarello CA; Ir D; Robertson CE; Ryan SM; Kroehl ME; Frank DN; Zipris D
    PLoS One; 2017; 12(3):e0173968. PubMed ID: 28301545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes?
    Fuhri Snethlage CM; de Wit D; Wortelboer K; Rampanelli E; Hanssen NMJ; Nieuwdorp M
    Immunol Rev; 2024 Aug; 325(1):46-63. PubMed ID: 38752578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
    Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
    J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease.
    Atkinson MA; Chervonsky A
    Diabetologia; 2012 Nov; 55(11):2868-77. PubMed ID: 22875196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human intestinal microbiota and type 1 diabetes.
    Vaarala O
    Curr Diab Rep; 2013 Oct; 13(5):601-7. PubMed ID: 23934614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of the role of gut dysbiosis in type 1 diabetes.
    Abdellatif AM; Sarvetnick NE
    J Diabetes; 2019 Aug; 11(8):632-644. PubMed ID: 30864231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.
    Needell JC; Zipris D
    Curr Diab Rep; 2016 Oct; 16(10):89. PubMed ID: 27523648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
    Wen L; Ley RE; Volchkov PY; Stranges PB; Avanesyan L; Stonebraker AC; Hu C; Wong FS; Szot GL; Bluestone JA; Gordon JI; Chervonsky AV
    Nature; 2008 Oct; 455(7216):1109-13. PubMed ID: 18806780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes.
    Elhag DA; Kumar M; Al Khodor S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Type 1 Diabetes.
    Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    Paun A; Yau C; Danska JS
    J Autoimmun; 2016 Jul; 71():10-8. PubMed ID: 26908163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome in type 1 diabetes: A comprehensive review.
    Zheng P; Li Z; Zhou Z
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3043. PubMed ID: 29929213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the gastrointestinal ecosystem in the development of type 1 diabetes.
    Daft JG; Lorenz RG
    Pediatr Diabetes; 2015 Sep; 16(6):407-18. PubMed ID: 25952017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.